Your browser doesn't support javascript.
loading
Factors affecting response of chemotherapy in women with ovarian cancer.
Lubin, J; Markowska, A; Knapp, P.
Affiliation
  • Lubin J; Clinic of Oncology in Poznan, Departament of Gynecology, Poznan, Poland. jola.lubin@gmail.com
Eur J Gynaecol Oncol ; 33(6): 644-7, 2012.
Article in En | MEDLINE | ID: mdl-23327063
Chemotherapy plays an important role in the treatment of ovarian cancer. Patients' response to chemotherapy is determined by a variety of acknowledged factors, but one might expect that many of them are yet to be described. The aim of this paper was to present the most essential yet still to be generally assessed in clinical practice, factors, which include: E-cadhedrin, hypoxia inducible factor alpha, survivin, COX-2, clusterin, BRCA1 protein, TP53 protein, YY1 protein, multidrug resistance protein, and interleukin-8.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Limits: Female / Humans Language: En Journal: Eur J Gynaecol Oncol Year: 2012 Document type: Article Affiliation country: Poland Country of publication: Singapore
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Limits: Female / Humans Language: En Journal: Eur J Gynaecol Oncol Year: 2012 Document type: Article Affiliation country: Poland Country of publication: Singapore